MCM7 affects the cisplatin resistance of liver cancer cells and the development of liver cancer by regulating the PI3K/Akt signaling pathway
Author:
Affiliation:
1. Department of Infectious Diseases, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/08923973.2021.1991372
Reference34 articles.
1. Hepatic arterial infusion in hepatocellular carcinoma: a single center experience
2. Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
3. Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma
4. FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo
5. Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long noncoding RNA DSCR8 promotes the proliferation of liver cancer cells and inhibits apoptosis via the miR-22-3p/ARPC5 Axis;Journal of Cancer;2023
2. Research progress on the P2X7 receptor in liver injury and hepatocellular carcinoma;Chemical Biology & Drug Design;2022-11-29
3. MCM2 in human cancer: functions, mechanisms, and clinical significance;Molecular Medicine;2022-10-27
4. Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer;Frontiers in Cell and Developmental Biology;2022-05-25
5. Kalman filtering under unknown inputs and norm constraints;Automatica;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3